Effectiveness of a telephone-based intervention for smoking cessation in patients with severe mental disorders: study protocol for a randomized controlled trial

Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMen...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Current controlled trials in cardiovascular medicine Ročník 20; číslo 1; s. 38 - 11
Hlavní autori: Ballbè, Montse, Martínez, Cristina, Feliu, Ariadna, Torres, Núria, Nieva, Gemma, Pinet, Cristina, Raich, Antònia, Mondon, Sílvia, Barrio, Pablo, Hernández-Ribas, Rosa, Vicens, Jordi, Costa, Sílvia, Vilaplana, Jordi, Alaustre, Laura, Vilalta, Eva, Blanch, Roser, Subirà, Susana, Bruguera, Eugeni, Suelves, Josep Maria, Guydish, Joseph, Fernández, Esteve
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 11.01.2019
BioMed Central Ltd
Springer Nature B.V
BMC
Predmet:
Abstinence
Biomedicine
Carbon monoxide
Care and treatment
Case studies
Clinical trial
Clinical trials
Estudi de casos
Health Sciences
Hospital patients
Hospitalization
Hypotheses
Information management
Intervention
Life expectancy
Medical protocols
Medical research
Medicine
Medicine & Public Health
Mental disorders
Mental health
Mentally ill persons
Methods
Motivation
Pathological psychology
Patient monitoring equipment
Patient outcomes
Protocols clínics
Psicopatologia
Psychiatric hospitals
Public health
Quality of life
Quitlines
Smoking
Smoking cessation
Statistics for Life Sciences
Study Protocol
Telemedicine
Telephone
Telèfon
Tobacco habit
Tobacco smoke
Tractament del tabaquisme
Spain
Smoking cessation
Clinical trial
Mental disorders
Telephone
Quitlines
ISSN:1745-6215, 1745-6215
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. Methods A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. Discussion This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System. Trial registration ClinicalTrials.gov, NCT03230955 . Registered on 24 July 2017.
AbstractList Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards.BACKGROUNDUp to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards.A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups.METHODSA pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups.This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System.DISCUSSIONThis trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System.ClinicalTrials.gov, NCT03230955 . Registered on 24 July 2017.TRIAL REGISTRATIONClinicalTrials.gov, NCT03230955 . Registered on 24 July 2017.
Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), [alpha] = 0.05, [beta] = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System.
Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System. ClinicalTrials.gov, NCT03230955 . Registered on 24 July 2017.
Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. Methods A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. Discussion This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System. Trial registration ClinicalTrials.gov, NCT03230955 . Registered on 24 July 2017.
BackgroundUp to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards.MethodsA pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals.Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups.DiscussionThis trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System.Trial registrationClinicalTrials.gov, NCT03230955. Registered on 24 July 2017.
Background: up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. Methods: a pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. Discussion: this trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System.
Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. Methods A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), [alpha] = 0.05, [beta] = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. Discussion This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System. Trial registration ClinicalTrials.gov, NCT03230955. Registered on 24 July 2017. Keywords: Mental disorders, Clinical trial, Smoking cessation, Telephone, Quitlines
Abstract Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized patients without monitoring after discharge quickly return to prehospitalization levels of tobacco use. The aim of the 061 QuitMental study is to assess the effectiveness of a multicomponent and motivational telephone-based intervention to stop smoking through a quitline addressed to smokers discharged from mental health hospital wards. Methods A pragmatic randomized controlled trial, single blinded, will include 2:1 allocation to the intervention group (IG) and the control group (CG). The IG will receive telephone assistance to quit smoking (including psychological and psychoeducational support, and pharmacological treatment advice if required) proactively for 12 months, and the CG will receive only brief advice after discharge. The sample size, calculated with an expected difference of 15 points on smoking abstinence between groups (IG, 20% and CG, 5%), α = 0.05, β = 0.10, and 20% loss, will be 334 participants (IG) and 176 participants (CG). Participants are adult smokers discharged from psychiatric units of five acute hospitals. Measurements include dependent variables (self-reported 7-day point prevalence smoking abstinence (carbon monoxide verified), duration of abstinence, number of quit attempts, motivation, and self-efficacy to quit) and independent variables (age, sex, and psychiatric diagnoses). In data analysis, IG and CG data will be compared at 48 h and 1, 6, and 12 months post discharge. Multivariate logistic regression (odds ratio; 95% confidence interval) of dependent variables adjusted for potential confounding variables will be performed. The number needed to treat to achieve one abstinence outcome will be calculated. We will compare the abstinence rate of enrolled patients between groups. Discussion This trial evaluates an innovative format of a quitline for smokers with severe mental disorders regardless of their motivation to quit. If effective, the pragmatic nature of the study will permit transfer to routine clinical practice in the National Health System. Trial registration ClinicalTrials.gov, NCT03230955. Registered on 24 July 2017.
ArticleNumber 38
Audience Academic
Author Feliu, Ariadna
Ballbè, Montse
Torres, Núria
Barrio, Pablo
Vilaplana, Jordi
Vicens, Jordi
Mondon, Sílvia
Martínez, Cristina
Raich, Antònia
Alaustre, Laura
Nieva, Gemma
Vilalta, Eva
Bruguera, Eugeni
Blanch, Roser
Hernández-Ribas, Rosa
Costa, Sílvia
Subirà, Susana
Fernández, Esteve
Pinet, Cristina
Guydish, Joseph
Suelves, Josep Maria
Author_xml – sequence: 1
  givenname: Montse
  surname: Ballbè
  fullname: Ballbè, Montse
  organization: Tobacco Control Unit, Cancer Control and Prevention Program, Institut Català d’Oncologia-ICO, Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Addictions Unit, Institute of Neurosciences, Hospital Clínic de Barcelona
– sequence: 2
  givenname: Cristina
  orcidid: 0000-0002-0108-3288
  surname: Martínez
  fullname: Martínez, Cristina
  email: cmartinez@iconcologia.net
  organization: Tobacco Control Unit, Cancer Control and Prevention Program, Institut Català d’Oncologia-ICO, Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Medicine and Health Sciences School, Universitat Internacional de Catalunya, Department of Clinical Sciences, School of Medicine, Universitat de Barcelona
– sequence: 3
  givenname: Ariadna
  surname: Feliu
  fullname: Feliu, Ariadna
  organization: Tobacco Control Unit, Cancer Control and Prevention Program, Institut Català d’Oncologia-ICO, Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Department of Clinical Sciences, School of Medicine, Universitat de Barcelona
– sequence: 4
  givenname: Núria
  surname: Torres
  fullname: Torres, Núria
  organization: 061 CatSalut Respon, Sistema d’Emergències Mèdiques
– sequence: 5
  givenname: Gemma
  surname: Nieva
  fullname: Nieva, Gemma
  organization: Smoking Cessation Unit, Addictive Behaviors Unit, Psychiatry Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Research, CIBERSAM, Universitat Autònoma de Barcelona
– sequence: 6
  givenname: Cristina
  surname: Pinet
  fullname: Pinet, Cristina
  organization: Addictive Behaviors Unit, Psychiatry Department, Hospital de la Santa Creu i Sant Pau
– sequence: 7
  givenname: Antònia
  surname: Raich
  fullname: Raich, Antònia
  organization: Mental Health Department, Althaia Xarxa Assistencial Universitària
– sequence: 8
  givenname: Sílvia
  surname: Mondon
  fullname: Mondon, Sílvia
  organization: Addictions Unit, Institute of Neurosciences, Hospital Clínic de Barcelona
– sequence: 9
  givenname: Pablo
  surname: Barrio
  fullname: Barrio, Pablo
  organization: Addictions Unit, Institute of Neurosciences, Hospital Clínic de Barcelona
– sequence: 10
  givenname: Rosa
  surname: Hernández-Ribas
  fullname: Hernández-Ribas, Rosa
  organization: Department of Clinical Sciences, School of Medicine, Universitat de Barcelona, Alcohol Program, Psychiatry Department, Hospital Universitari de Bellvitge, Institut Català d’Oncologia, IDIBELL, CIBERSAM
– sequence: 11
  givenname: Jordi
  surname: Vicens
  fullname: Vicens, Jordi
  organization: Psychiatry Department, Hestia Duran i Reynals
– sequence: 12
  givenname: Sílvia
  surname: Costa
  fullname: Costa, Sílvia
  organization: Addictive Behaviors Unit, Psychiatry Department, Hospital de la Santa Creu i Sant Pau, Institut d’Investigació Biomèdica Sant Pau
– sequence: 13
  givenname: Jordi
  surname: Vilaplana
  fullname: Vilaplana, Jordi
  organization: Lleida Institute for Biomedical Research Dr. Pifarré Foundation, IRBLleida, Universitat de Lleida
– sequence: 14
  givenname: Laura
  surname: Alaustre
  fullname: Alaustre, Laura
  organization: 061 CatSalut Respon, Sistema d’Emergències Mèdiques
– sequence: 15
  givenname: Eva
  surname: Vilalta
  fullname: Vilalta, Eva
  organization: 061 CatSalut Respon, Sistema d’Emergències Mèdiques
– sequence: 16
  givenname: Roser
  surname: Blanch
  fullname: Blanch, Roser
  organization: 061 CatSalut Respon, Sistema d’Emergències Mèdiques
– sequence: 17
  givenname: Susana
  surname: Subirà
  fullname: Subirà, Susana
  organization: Psychiatry Department, Hestia Duran i Reynals
– sequence: 18
  givenname: Eugeni
  surname: Bruguera
  fullname: Bruguera, Eugeni
  organization: Smoking Cessation Unit, Addictive Behaviors Unit, Psychiatry Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Research, CIBERSAM, Universitat Autònoma de Barcelona
– sequence: 19
  givenname: Josep Maria
  surname: Suelves
  fullname: Suelves, Josep Maria
  organization: Public Health Agency of Catalonia, Health Department, Government of Catalonia
– sequence: 20
  givenname: Joseph
  surname: Guydish
  fullname: Guydish, Joseph
  organization: Philip R. Lee Institute for Health Policy Studies, University of California San Francisco
– sequence: 21
  givenname: Esteve
  surname: Fernández
  fullname: Fernández, Esteve
  organization: Tobacco Control Unit, Cancer Control and Prevention Program, Institut Català d’Oncologia-ICO, Cancer Control and Prevention Group, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Department of Clinical Sciences, School of Medicine, Universitat de Barcelona
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30635072$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQjVARbRd-ABdkiQuXFDuO44QDUlUVqFSJC5wtxxlvXRJ7sb2Lyq_hpzLZ7ccWAYqiTCbvvck8v-PiwAcPRfGS0RPG2uZtYpw2vKSsLTmjTSmeFEdM1qJsKiYO9urD4jila0pr3vH6WXE40wSV1VHx69xaMNltwENKJFiiSYYRVlc4qux1goE4nyEiILvgiQ2RpCl8c35JDFL0tus8WWGFmER-uHxFEmwgApmwo0cyuBTiADG9IymvhxuyiiEHE8atnCZR-yFM7icOM8HnGMYRyxydHp8XT60eE7y4fS6Krx_Ov5x9Ki8_f7w4O70sTVOLXLKKGW64BVk3nIuh5czKCqQGWve07RttmbHUdsDAGFvZihthNTWD5a3sDV8UFzvdIehrtYpu0vFGBe3UthHiUumYnRlBaStZV7dcU4GzgXaS6r6zrJW0ZzVauyje77RW636CwaAJUY-PRB9_8e5KLcNGNbzqqKhRgO0ETFobFcFANDpvifcv813hGSqOhHbmvLkdGsP3NaSsJpcMjKP2ENZJVUx2XMiaM4S-_gN6HdbRo72qkp3gbdW28gG11Li08zbgv5pZVJ2KFhfFNM1aJ39B4TXA5PAwwTrsPyK82jfn3pW7TCJA3i4fQ0oRrDIub2OGym5UjKo5_WqXfoXpV3P6ldiz7Y55J_4_TrXjJMT6JcQHL_5N-g1fUxj-
CitedBy_id crossref_primary_10_1097_JAN_0000000000000353
crossref_primary_10_1016_j_drugalcdep_2022_109390
crossref_primary_10_1016_j_addbeh_2021_106988
crossref_primary_10_1007_s11469_024_01254_8
Cites_doi 10.1080/14622200802027198
10.1017/S0033291796004242
10.1016/j.schres.2017.04.018
10.1136/bmj.g1151
10.1177/1078390308330050
10.1001/archpsyc.1986.01800030107013
10.1016/j.psychres.2014.06.035
10.1136/eb-2012-100890
10.1093/ntr/ntu252
10.1080/10550490500419011
10.1016/j.jpsychires.2013.09.014
10.1136/bmjopen-2014-006414
10.1146/annurev.publhealth.012809.103701
10.1177/0004867417692424
10.1176/appi.ps.002852012
10.1001/archpsyc.61.11.1107
10.1111/j.1360-0443.2009.02545.x
10.1093/ije/dyt014
10.1111/j.1360-0443.2010.02946.x
10.1093/ntr/ntu097
10.2105/AJPH.2013.301403
10.1001/jama.2010.1769
10.20882/adicciones.192
10.1037/0003-066X.47.9.1102
10.1001/jamapsychiatry.2014.2502
10.1155/2015/817298
10.1016/j.drugalcdep.2012.03.022
10.1016/j.amepre.2015.01.016
10.1016/j.addbeh.2014.08.005
10.1016/j.genhosppsych.2009.08.003
10.1080/00048670701392809
10.1111/j.1360-0443.1991.tb01879.x
10.5498/wjp.v5.i1.35
10.1080/1462220031000070552
10.1136/tobaccocontrol-2011-050029
10.1016/j.amepre.2015.10.004
10.1001/jama.284.20.2606
10.1111/dar.12475
10.1016/j.addbeh.2005.02.001
10.1192/bjp.bp.109.067512
10.1056/NEJMcp1101512
10.1017/S2045796017000166
10.1371/journal.pone.0019590
10.1093/ntr/ntu173
10.1136/tobaccocontrol-2014-051585
10.1080/j.1440-1614.2005.01697.x
10.1176/appi.books.9780890425596
ContentType Journal Article
Contributor Universitat de Barcelona
Contributor_xml – sequence: 1
  fullname: Universitat de Barcelona
Copyright The Author(s). 2019
COPYRIGHT 2019 BioMed Central Ltd.
The Author(s). 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
cc-by (c) Ballbè i Gibernau, Montse et al., 2019 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es
Copyright_xml – notice: The Author(s). 2019
– notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: The Author(s). 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: cc-by (c) Ballbè i Gibernau, Montse et al., 2019 info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by/3.0/es">http://creativecommons.org/licenses/by/3.0/es</a>
DBID C6C
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
XX2
5PM
DOA
DOI 10.1186/s13063-018-3106-5
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Recercat
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1745-6215
EndPage 11
ExternalDocumentID oai_doaj_org_article_af719483a05645e0970ab9f1870b1406
PMC6329054
oai_recercat_cat_2072_354384
A581404391
30635072
10_1186_s13063_018_3106_5
Genre Journal Article
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GrantInformation_xml – fundername: Instituto Carlos III (ISCIII)
  grantid: PI15/00875
– fundername: ;
  grantid: PI15/00875
GroupedDBID ---
0R~
123
2-G
29Q
2WC
53G
5VS
6PF
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OVT
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
WOQ
WOW
~8M
AAYXX
AFFHD
CITATION
ALIPV
NPM
3V.
5GY
7XB
8FK
AHMBA
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
XSB
7X8
XX2
5PM
ID FETCH-LOGICAL-c645t-121c3c3fe746335d831f72e7ae04b08b6af1cf0f9e1eccf2f23c5fa0cdf387bc3
IEDL.DBID 7RV
ISICitedReferencesCount 5
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000455531100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1745-6215
IngestDate Tue Oct 14 18:53:26 EDT 2025
Tue Nov 04 01:37:39 EST 2025
Fri Nov 07 13:56:50 EST 2025
Thu Oct 02 10:50:16 EDT 2025
Sun Oct 19 01:38:31 EDT 2025
Tue Nov 11 10:40:56 EST 2025
Tue Nov 04 17:48:20 EST 2025
Thu Apr 03 07:12:13 EDT 2025
Sat Nov 29 06:11:15 EST 2025
Tue Nov 18 22:20:51 EST 2025
Sat Sep 06 07:26:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Smoking cessation
Clinical trial
Mental disorders
Telephone
Quitlines
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c645t-121c3c3fe746335d831f72e7ae04b08b6af1cf0f9e1eccf2f23c5fa0cdf387bc3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
ORCID 0000-0002-0108-3288
OpenAccessLink https://www.proquest.com/docview/2795382887?pq-origsite=%requestingapplication%
PMID 30635072
PQID 2795382887
PQPubID 44365
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_af719483a05645e0970ab9f1870b1406
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6329054
csuc_recercat_oai_recercat_cat_2072_354384
proquest_miscellaneous_2179357431
proquest_journals_2795382887
gale_infotracmisc_A581404391
gale_infotracacademiconefile_A581404391
pubmed_primary_30635072
crossref_citationtrail_10_1186_s13063_018_3106_5
crossref_primary_10_1186_s13063_018_3106_5
springer_journals_10_1186_s13063_018_3106_5
PublicationCentury 2000
PublicationDate 2019-01-11
PublicationDateYYYYMMDD 2019-01-11
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-11
  day: 11
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Current controlled trials in cardiovascular medicine
PublicationTitleAbbrev Trials
PublicationTitleAlternate Trials
PublicationYear 2019
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References D Shmueli (3106_CR25) 2008; 10
K Rocha Pérez (3106_CR48) 2011; 11
JJ Prochaska (3106_CR21) 2014; 104
A Raich (3106_CR32) 2015; 27
D Olivier (3106_CR9) 2007; 41
LM Hickling (3106_CR10) 2018; 192
AV Lukowski (3106_CR51) 2015; 17
JJ Prochaska (3106_CR34) 2006; 15
ML Steinberg (3106_CR3) 2015; 49
J Westman (3106_CR15) 2018; 27
G Taylor (3106_CR37) 2014; 348
L Twyman (3106_CR22) 2014; 4
CK Chang (3106_CR17) 2011; 6
J Bowman (3106_CR33) 2013; 16
LF Stead (3106_CR38) 2013; 8
RC Callaghan (3106_CR13) 2018; 37
BF Grant (3106_CR7) 2004; 61
JR Hughes (3106_CR41) 2003; 5
CD Morris (3106_CR39) 2009; 15
ER Walker (3106_CR16) 2015; 72
F Manzella (3106_CR11) 2015; 5
AL Baker (3106_CR53) 2014; 220
AP Metse (3106_CR36) 2017; 51
3106_CR19
3106_CR6
3106_CR18
Ballbè M coordinadors GA (3106_CR28) 2012
KA Vickerman (3106_CR50) 2015; 2015
R Secades-Villa (3106_CR1) 2013; 64
American Psychiatric Association (3106_CR46) 2013
ES Rogers (3106_CR52) 2016; 50
TF Heatherton (3106_CR45) 1991; 86
E Ratschen (3106_CR24) 2009; 31
H Chabrol (3106_CR44) 2005; 30
L Szatkowski (3106_CR2) 2015; 17
M Ballbe (3106_CR40) 2012; 21
M Ballbe (3106_CR5) 2014; 24
S Lawn (3106_CR23) 2005; 39
JR Hughes (3106_CR42) 1986; 43
C Martinez (3106_CR29) 2015; 40
JO Prochaska (3106_CR43) 1992; 47
SA Schroeder (3106_CR20) 2010; 31
M Ballbe (3106_CR26) 2013; 42
MC Fiore (3106_CR27) 2011; 365
S Brown (3106_CR14) 2010; 196
M McFall (3106_CR31) 2010; 304
A Bandura (3106_CR49) 1986
K Lasser (3106_CR4) 2000; 284
EA Stockings (3106_CR35) 2014; 16
RC Callaghan (3106_CR12) 2014; 48
DP Goldberg (3106_CR47) 1997; 27
KD Ward (3106_CR8) 2012; 125
L Banham (3106_CR30) 2010; 105
References_xml – volume-title: Guia d’intervenció clínica en el consum de tabac en pacients amb trastorn mental
  year: 2012
  ident: 3106_CR28
– volume: 10
  start-page: 875
  year: 2008
  ident: 3106_CR25
  publication-title: Nicotine Tob Res
  doi: 10.1080/14622200802027198
– volume: 27
  start-page: 191
  year: 1997
  ident: 3106_CR47
  publication-title: Psychol Med
  doi: 10.1017/S0033291796004242
– volume: 192
  start-page: 269
  year: 2018
  ident: 3106_CR10
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2017.04.018
– volume: 348
  start-page: g1151
  year: 2014
  ident: 3106_CR37
  publication-title: BMJ
  doi: 10.1136/bmj.g1151
– volume: 15
  start-page: 32
  year: 2009
  ident: 3106_CR39
  publication-title: J Am Psychiatr Nurses Assoc
  doi: 10.1177/1078390308330050
– volume: 43
  start-page: 289
  year: 1986
  ident: 3106_CR42
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1986.01800030107013
– volume: 220
  start-page: 63
  year: 2014
  ident: 3106_CR53
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2014.06.035
– volume: 16
  start-page: 21
  year: 2013
  ident: 3106_CR33
  publication-title: Evid Based Nurs
  doi: 10.1136/eb-2012-100890
– volume: 17
  start-page: 924
  year: 2015
  ident: 3106_CR51
  publication-title: Nicotine Tob Res
  doi: 10.1093/ntr/ntu252
– volume: 15
  start-page: 15
  year: 2006
  ident: 3106_CR34
  publication-title: Am J Addict
  doi: 10.1080/10550490500419011
– volume: 48
  start-page: 102
  year: 2014
  ident: 3106_CR12
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2013.09.014
– volume: 4
  start-page: e006414
  year: 2014
  ident: 3106_CR22
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2014-006414
– volume: 31
  start-page: 297
  year: 2010
  ident: 3106_CR20
  publication-title: Annu Rev Public Health
  doi: 10.1146/annurev.publhealth.012809.103701
– volume: 51
  start-page: 366
  year: 2017
  ident: 3106_CR36
  publication-title: Aust N Z J Psychiatry
  doi: 10.1177/0004867417692424
– volume: 64
  start-page: 458
  year: 2013
  ident: 3106_CR1
  publication-title: Psychiatr Serv
  doi: 10.1176/appi.ps.002852012
– volume: 61
  start-page: 1107
  year: 2004
  ident: 3106_CR7
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.11.1107
– ident: 3106_CR19
  doi: 10.1111/j.1360-0443.2009.02545.x
– volume: 42
  start-page: 886
  year: 2013
  ident: 3106_CR26
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyt014
– volume: 105
  start-page: 1176
  year: 2010
  ident: 3106_CR30
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2010.02946.x
– volume: 16
  start-page: 1417
  year: 2014
  ident: 3106_CR35
  publication-title: Nicotine Tob Res
  doi: 10.1093/ntr/ntu097
– volume: 104
  start-page: 1557
  year: 2014
  ident: 3106_CR21
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.2013.301403
– volume: 304
  start-page: 2485
  year: 2010
  ident: 3106_CR31
  publication-title: JAMA
  doi: 10.1001/jama.2010.1769
– volume: 27
  start-page: 37
  year: 2015
  ident: 3106_CR32
  publication-title: Adicciones
  doi: 10.20882/adicciones.192
– volume: 8
  start-page: CD002850
  year: 2013
  ident: 3106_CR38
  publication-title: Cochrane Database Syst Rev
– volume: 47
  start-page: 1102
  year: 1992
  ident: 3106_CR43
  publication-title: Am Psychol
  doi: 10.1037/0003-066X.47.9.1102
– volume-title: Social foundations of thought and action: a social cognitive theory
  year: 1986
  ident: 3106_CR49
– volume: 72
  start-page: 334
  year: 2015
  ident: 3106_CR16
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2014.2502
– volume: 11
  start-page: 125
  year: 2011
  ident: 3106_CR48
  publication-title: Int J Clin Health Psychol
– volume: 2015
  start-page: 817298
  year: 2015
  ident: 3106_CR50
  publication-title: Biomed Res Int
  doi: 10.1155/2015/817298
– volume: 125
  start-page: 95
  year: 2012
  ident: 3106_CR8
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2012.03.022
– volume: 49
  start-page: 362
  year: 2015
  ident: 3106_CR3
  publication-title: Am J Prev Med
  doi: 10.1016/j.amepre.2015.01.016
– volume: 40
  start-page: 1
  year: 2015
  ident: 3106_CR29
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2014.08.005
– volume: 31
  start-page: 576
  year: 2009
  ident: 3106_CR24
  publication-title: Gen Hosp Psychiatry
  doi: 10.1016/j.genhosppsych.2009.08.003
– volume: 41
  start-page: 572
  year: 2007
  ident: 3106_CR9
  publication-title: Aust N Z J Psychiatry
  doi: 10.1080/00048670701392809
– volume: 86
  start-page: 1119
  year: 1991
  ident: 3106_CR45
  publication-title: Br J Addict
  doi: 10.1111/j.1360-0443.1991.tb01879.x
– volume: 5
  start-page: 35
  year: 2015
  ident: 3106_CR11
  publication-title: World J Psychiatry
  doi: 10.5498/wjp.v5.i1.35
– volume: 5
  start-page: 13
  year: 2003
  ident: 3106_CR41
  publication-title: Nicotine Tob Res
  doi: 10.1080/1462220031000070552
– volume: 21
  start-page: 549
  year: 2012
  ident: 3106_CR40
  publication-title: Tob Control
  doi: 10.1136/tobaccocontrol-2011-050029
– volume: 50
  start-page: 518
  year: 2016
  ident: 3106_CR52
  publication-title: Am J Prev Med
  doi: 10.1016/j.amepre.2015.10.004
– volume: 284
  start-page: 2606
  year: 2000
  ident: 3106_CR4
  publication-title: JAMA
  doi: 10.1001/jama.284.20.2606
– volume: 37
  start-page: 97
  year: 2018
  ident: 3106_CR13
  publication-title: Drug Alcohol Rev
  doi: 10.1111/dar.12475
– volume: 30
  start-page: 1474
  year: 2005
  ident: 3106_CR44
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2005.02.001
– volume: 196
  start-page: 116
  year: 2010
  ident: 3106_CR14
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.109.067512
– volume: 365
  start-page: 1222
  year: 2011
  ident: 3106_CR27
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp1101512
– ident: 3106_CR18
– volume: 27
  start-page: 519
  year: 2018
  ident: 3106_CR15
  publication-title: Epidemiol Psychiatr Sci
  doi: 10.1017/S2045796017000166
– volume: 6
  start-page: e19590
  issue: 5
  year: 2011
  ident: 3106_CR17
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019590
– volume: 17
  start-page: 356
  year: 2015
  ident: 3106_CR2
  publication-title: Nicotine Tob Res
  doi: 10.1093/ntr/ntu173
– volume: 24
  start-page: E212
  year: 2014
  ident: 3106_CR5
  publication-title: Tob Control
  doi: 10.1136/tobaccocontrol-2014-051585
– volume: 39
  start-page: 866
  year: 2005
  ident: 3106_CR23
  publication-title: Aust N Z J Psychiatry
  doi: 10.1080/j.1440-1614.2005.01697.x
– volume-title: Diagnostic and statistical manual of mental disorders: DSM-5
  year: 2013
  ident: 3106_CR46
  doi: 10.1176/appi.books.9780890425596
– ident: 3106_CR6
SSID ssj0043934
ssj0017864
Score 2.2054179
Snippet Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population....
Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized...
Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population....
Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population. Hospitalized...
BackgroundUp to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population....
Background: up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general population....
Abstract Background Up to 75% of inpatients with mental disorders smoke, and their life expectancy is decreased by up to 25 years compared to the general...
SourceID doaj
pubmedcentral
csuc
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 38
SubjectTerms Abstinence
Biomedicine
Carbon monoxide
Care and treatment
Case studies
Clinical trial
Clinical trials
Estudi de casos
Health Sciences
Hospital patients
Hospitalization
Hypotheses
Information management
Intervention
Life expectancy
Medical protocols
Medical research
Medicine
Medicine & Public Health
Mental disorders
Mental health
Mentally ill persons
Methods
Motivation
Pathological psychology
Patient monitoring equipment
Patient outcomes
Protocols clínics
Psicopatologia
Psychiatric hospitals
Public health
Quality of life
Quitlines
Smoking
Smoking cessation
Statistics for Life Sciences
Study Protocol
Telemedicine
Telephone
Telèfon
Tobacco habit
Tobacco smoke
Tractament del tabaquisme
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEA6yiPgi_rZ6SgRBUMolTdokvp3i4YMePijcW0jTBBfutrLt-nB_zf2pzqTZdXuivviwsLtJu5uZ6XwzyeQLIS-a0Lima33ZdkGW0gUFjxSyiGrWdkLENoS0UfijOjnRp6fm895RX1gTNtEDT4I7dFFBnq2FY8h7EphRzLUmcrCzFpKDRLYNUc82mZp8MKCskHkNk-vmcABPjeuVHOcCIYWuZyi08MPGZ87-3z3zHjRdLZu8snaaIOn4NrmVY0l6NI3hDrkWVnfJjU95tfweuZyoibM_o32kjo4AM1iOHkrEr44u92oeKQSwdDjvcfac4vaBpDXoQjP76kBx2pYCmIZ1oNOxALTL_J3DG5q4ailSP_RgX-l2jgIYdv358gJ-LNfFn8HbdFrIffL1-P2Xdx_KfCJD6UH4Y8kr7oUXMSjZCFF3WvCoqqBcYLJlum1c5D6yaAIH04hVrISvo2O-i0Kr1osHZLGCIT4i1DkdWZBIONdKiBpNVxtpIJhzstPRxIKwrYasz3TleGrGmU1pi27spFQLSrWoVFsX5NXuku8TV8ffO4PaLeBKWHs3WuTZ3n3AV8VUZUUthZYFeYvGsbsr9k1fgKXabKn2X5ZakJdoWhY9B4zEu7wBAuSBHFz2qNaJ68jwghzMesIT7-fNW-O02eMMtlIGsKsCzCjI810zXolVdKvQb6APeuMaY8aCPJxseTckFA_kBlVB1MzKZ2Oet6yW3xIfeSMqA5F_QV5vn4dff-uP8n_8P0T6hNyEABYL_krOD8hiXG_CU3Ld_xiXw_pZcgk_AQehZbI
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Springer Nature Consortium list (Orbis Cascade Alliance)
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELagIMSF9yOwICMhIYGitWMnsbktiBUHWCFe2pvlODZU2m1Q0nLg1_BTmXGcslkeEhwqtfUkrScz34zt8WdCHla-slXbuLxpvcyl9TW4FLKIKta0QoTG-7hR-FV9cKAOD_WbtI97mKrdpyXJiNTRrVW1OwDa4pojx_k8GAaXZ8k5iHYKvfHtu48T_EKAFTItX_72slkAWrhh4xJd_6-gfCIqna6YPLVsGqPR_uX_6scVcikln3RvtJar5IxfXSMXXqfl9evk-8hlnACQdoFauoa4hPXrPseA19LliSJJChkvHY47nG6nuN8gPmYQoYmudaA4z0sh-vre0_EcAdomws_hKY3kthS5IjowyHg7SyF6tt3x8hv8WCqkP4K38XiRG-TD_ov3z1_m6QiH3FWyXOe84E44EXwtKyHKVgke6sLX1jPZMNVUNnAXWNCegy2FIhTClcEy1wah6saJm2Sxgi7eJtRaFZiXyFDXSEgzdVtqqSH7s7JVQYeMsOm5Gpf4zfGYjSMTxzmqMqPmDWjeoOZNmZHH20u-jOQefxcGYzEQiHzv7NogMff2A74KVhdGlFIomZFnaFLbu6Js_KLrP5mECcaGmmuphGVI6eOZrpltdOAAoQ2Me6uMPEKDNAg10BNn044J0AeSdpm9UkVyJM0zsjOTBIhw8-bJpE2CqMEUtYZgV0CQyciDbTNeiWV3K99tQAbhu8QkMyO3Rg_YdgnVA4OJIiP1zDdmfZ63rJafI4F5JQoNQ4WMPJk85Off-qP-7_yT9F1yEVJbLAXMOd8hi3W_8ffIefd1vRz6-xExfgA7kGqi
  priority: 102
  providerName: Springer Nature
Title Effectiveness of a telephone-based intervention for smoking cessation in patients with severe mental disorders: study protocol for a randomized controlled trial
URI https://link.springer.com/article/10.1186/s13063-018-3106-5
https://www.ncbi.nlm.nih.gov/pubmed/30635072
https://www.proquest.com/docview/2795382887
https://www.proquest.com/docview/2179357431
https://recercat.cat/handle/2072/354384
https://pubmed.ncbi.nlm.nih.gov/PMC6329054
https://doaj.org/article/af719483a05645e0970ab9f1870b1406
Volume 20
WOSCitedRecordID wos000455531100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: RBZ
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: 7X7
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: 7RV
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: BENPR
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: PIMPY
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature Consortium list (Orbis Cascade Alliance)
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: RSV
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELagQwgJ8WMMCIzJSEhIoGhx7MQOL2hDm0BiVTVgGk-W49hQaWtG0_LAX8Ofyp3jdusQe-GhUV07ac_9fGffnT8T8qJ0pSmb2qZ140QqjJMwpJBFVGV1w7mvnQsbhT_K4VAdH1ej6HDrYlrlQicGRd20Fn3k27msYGzmMCbenv1I8dQojK7GIzSukzWGthvwLA-PllEEqUoRI5lMldsd6GuMWjL0CMJCulixRQPbzW1k7v9bP18wUJeTJy9FUINh2r_7vyLdI3filJTu9Bi6T665yTq5eRCD7uvkdu_ao_2OpQfkd894HNUkbT01dAbWC7PcXYpmsaHjC6mUFObFtDtt0SlPcVdCAAM0oZHUtaPoDaZgo93U0f60AdpEWtDuDQ0UuBQZJVqAbXicoWBjm_Z0_Au-LKbbn8DbcAjJBvmyv_f53fs0HvSQ2lIUs5TlzHLLvZOi5LxoFGde5k4al4k6U3VpPLM-85VjgDif-5zbwpvMNp4rWVv-kAwmIOJjQo1RPnMCeexqAZPRqikqUcEc0YhG-conJFv85dpGFnQ8jONEh9WQKnWPEg0o0YgSXSTk1fKWs54C5OrGgCMN5spNrZlppO9eFvCVZzLXvBBciYTsItqWT8W24YN2-k1HzaGNl6wSipsMiX9cVsnM1JVnoGhrWB2XCXmJWNWokEASa-K-CugPpPbSO4UKFEoVS8jmSktQJHa1egFTHRVZp88xmpDny2q8E5PzJq6dQxtU8gVORRPyqB8cS5Gwe2DJkSdErgybFZlXaybj74HmvOR5BQuKhLxeDLDzn_XP_n9ytRBPyS2Y8WKGYMrYJhnMpnP3jNywP2fjbroVtAdej2W4qi2ytrs3HB1uBVcNlEYfDkZfoXT46egP5tSBpg
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aAwES4jJugQFGAiGBosVxEjtICI3LtGkX8TCkvhnHsaHS1oymA8Gv4RfwGzkncbt1iL3tgYdKbeM4Pe652ud8B-BJ4QpT1JWNq9plcWacRJEiFFGVVLUQvnKuKxTekjs7ajAoPyzA72ktDKVVTnVip6jrxtIe-UoqS5TNFGXi9cHXmLpG0enqtIVGzxab7sd3DNnaVxvv8P99mqZr73ffrsehq0BsiyyfxDzlVljhncwKIfJaCe5l6qRxSVYlqiqM59YnvnQcyfOpT4XNvUls7YWSlRU47zk4j3pcUgqZHMwCPC5VkYWTU66KlRbtA52SctqBxMA9n7N9i7Y9tKFTwN_24JhBPJmseeLEtjOEa9f-tyW8DleDy81Wexm5AQtutAQXt0NSwRJc6bcuWV-RdRN-9YjOwQywxjPDJmidKYvfxWT2azY8lirK0O9n7X5Dhw6Mqi46ZschLIDWtox2uxn6IG7sWN9NgdUB9rR9yTqIX0aIGQ2KZTedYehD1M3-8Cc-LJQT7OHbrsnKLfh4Jut1GxZHSOJdYMYon7iMcPqqDJ3tss7LrEQf2GS18qWPIJmymLYB5Z2ajezpLtpThe65UiNXauJKnUfwfHbLQQ9xcvpg5FuN5tiNrZlogieffaBXmshUizwTKovgDXH3bFYa233RjD_roBm18ZKXmRImIWAjl5QyMVXpORqSCqP_IoJnJBuaFC5SYk2oG8H1IOgyvZqrDiKq5BEsz41ERWnnL0_FQgdF3eojmYjg8ewy3UnJhyPXHOIYMmI5udoR3OmFcUYSLQ-GVGkEck5M52ievzIafulg3AuRlhgwRfBiKtBHP-uf63_vdCIewaX13e0tvbWxs3kfLqN3T9mQMefLsDgZH7oHcMF-mwzb8cNOczH4dNZy_ge8Tdoq
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aA01IiMu4BQYYCYQ0FC2Ok9hBQmgwJqaNaQ8g9c04jg2VtmY0HQh-Db-DX8c5idutQ-xtDzxUahvHqd3znYt9_B2AJ4UrTFFXNq5ql8WZcRIhRSyiKqlqIXzlXHdQeEfu7qrBoNxbgN_TszCUVjnViZ2irhtLa-RrqSwRmyliYs2HtIi9jc1Xh19jqiBFO63Tchq9iGy7H98xfGtfbm3gf_00TTfffnjzLg4VBmJbZPkk5im3wgrvZFYIkddKcC9TJ41LsipRVWE8tz7xpeM4VJ_6VNjcm8TWXihZWYH9XoCLUghJZSPkYBbscamKLOyiclWstWgraMeU02okBvH5nB1ctO2RDVUD_rYNJ4zj6cTNU7u3nVHcvPY_T-d1uBpccbbeY-cGLLjRMiy9D8kGy3ClX9Jk_Umtm_CrZ3oO5oE1nhk2QatN2f0uJnegZsMTKaQM4wHWHjS0GcHoNEYHAmzCAplty2gVnKFv4saO9VUWWB3oUNsXrKP-ZcSk0SBcu-4MQ9-ibg6GP_Fh4ZjBPr7tiq_cgo_nMl-3YXGEQ7wLzBjlE5cRf1-VoRNe1nmZlegbm6xWvvQRJFNx0zawv1MRkn3dRYGq0L2EapRQTRKq8whWZ7cc9tQnZzdGGdZopt3Ymokm2vLZB3qliUy1yDOhsghek6TPeqW23RfN-LMOGlMbL3mZKWESIjxySSkTU5Weo4GpOLqhETwjnGhSxDgSa8J5EpwPojTT67nqqKNKHsHKXEtUoHb-8hQiOijwVh_jI4LHs8t0JyUljlxzhG3IuOXkgkdwpwfmbEg0PRhqpRHIOcjOjXn-ymj4paN3L0RaYiAVwfMpuI9_1j_n_97Zg3gESwhvvbO1u30fLqPTT0mSMecrsDgZH7kHcMl-mwzb8cNOiTH4dN4w_wPyfuLe
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effectiveness+of+a+telephone-based+intervention+for+smoking+cessation+in+patients+with+severe+mental+disorders%3A+study+protocol+for+a+randomized+controlled+trial&rft.jtitle=Trials&rft.au=Ballb%C3%A8%2C+Montse&rft.au=Mart%C3%ADnez%2C+Cristina&rft.au=Feliu%2C+Ariadna&rft.au=Torres%2C+N%C3%BAria&rft.date=2019-01-11&rft.pub=BioMed+Central+Ltd&rft.issn=1745-6215&rft.eissn=1745-6215&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs13063-018-3106-5&rft.externalDocID=A581404391
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon